Anna Catalanotto

In part two of an interview, Cardinal Health’s Anna Catalanotto discusses how collaboration, payer education, and streamlined treatment-site workflows accelerate patient access to complex cell and gene therapies.

In part one of an interview with Cardinal Health’s Anna Catalanotto, Catalanotto outlines how early, payer-informed commercialization planning keeps cell and gene therapies accessible and financially viable.